The 130th Annual Meeting of APHA

Abstract #52680

Martin T. Donahoe, MD FACP, Center for Ethics in Health Care, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97201-3098, N/A, anna.keller@apha.org

Learning Objectives:

The History of Drug Development in the United States
• Describe key events in the history of drug regulation in the United States.
• Explain key items of legislation which determine how drugs are regulated.
• Assess the FDA Modernization and Accountability Act.

Keywords: Drugs,

Presenting author's disclosure statement:
I do not have any significant financial interest/arrangement or affiliation with any organization/institution whose products or services are being discussed in this session.